CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(02): E214-E220
DOI: 10.1055/a-1038-3973
Innovation forum
Owner and Copyright © Georg Thieme Verlag KG 2020

A new procedure combining local resection with endoscopic submucosal dissection for low rectal tumor: a four-case series

Naoki Asayama
1   Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
,
Shinji Nagata
1   Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
,
Masashi Miguchi
2   Department of Surgery, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
,
Kenjiro Shigita
1   Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
,
Taiki Aoyama
1   Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
,
Akira Fukumoto
1   Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
,
Shinichi Mukai
1   Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan
› Author Affiliations
Further Information

Publication History

submitted 26 March 2019

accepted after revision 05 August 2019

Publication Date:
28 January 2020 (online)

Abstract

Rectal tumors are traditionally resected by proctectomy to ensure the achievement of negative margins, an approach associated with an adverse impact on subsequent quality of life due to sequelae such as permanent stoma and urinary and sexual dysfunction. Many studies have now demonstrated that recurrence after local excision of early rectal tumors is significantly higher than would typically be expected. We have developed a new procedure, described herein, that combines local resection with endoscopic submucosal dissection for low rectal tumor. We report four consecutive cases (three submucosal tumors and one tumor with clinical deep submucosal invasion) treated at Hiroshima City Asa Citizens Hospital between January 2009 and March 2018. The mean duration of the procedure was 137 minutes. The en bloc resection and histologically complete resection rates were 100 %. Delayed bleeding and perforation rates were 0 %. Postoperative complications were fever and anal pain (one case each). All patients recovered with conservative therapy. No recurrence was found in any of the four patients during a follow-up period of 56 months. Our combined endoscopic and surgical procedure for low rectal tumors enabled definite negative vertical margins, reduced tumor volume, allowed for accurate pathological diagnosis, preserved rectal function, and aided the decision on additional therapy.

 
  • References

  • 1 Jones HJS, Goodbrand S, Hompes R. et al. Radiotherapy after local excision of rectal cancer may offer reduced local recurrence rates. Colorectal Dis 2019; 21: 451-459
  • 2 Junginger T, Goenner U, Hitzler M. et al. Analysis of local recurrences after transanal endoscopic microsurgery for low risk rectal carcinoma. Int J Colorectal Dis 2017; 32: 265-271
  • 3 Kiriyama S, Saito Y, Matsuda T. et al. Comparing endoscopic submucosal dissection with transanal resection for non-invasive rectal tumor: a retrospective study. J Gastroenterol Hepatol 2011; 26: 1028-1033
  • 4 Oka S, Tanaka S, Saito Y. et al. Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am J Gastroenterol 2015; 110: 697-707
  • 5 Asayama N, Oka S, Tanaka S. et al. Endoscopic submucosal dissection as total excisional biopsy for clinical T1 colorectal carcinoma. Digestion 2015; 91: 64-69
  • 6 Imai K, Hotta K, Yamaguchi Y. et al. Safety and efficacy of endoscopic submucosal dissection of rectal tumors extending to the dentate line. Endoscopy 2015; 47: 529-532
  • 7 Tamaru Y, Oka S, Tanaka S. et al. Endoscopic submucosal dissection for anorectal tumor with hemorrhoids close to the dentate line: a multicenter study of Hiroshima GI Endoscopy Study Group. Surg Endosc 2016; 30: 4425-4431
  • 8 Matsumoto S, Mashima H. The efficacy of endoscopic submucosal dissection for colorectal tumors extending to the dentate line. Int J Colorectal Dis 2017; 32: 831-837
  • 9 Saito T, Toyoda H, Yamaguchi M. et al. Ileocolonic lymphomas: a series of 16 cases. Endoscopy 2005; 37: 466-469
  • 10 Kim SJ, Choi CW, Mun YC. et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC Cancer 2011; 11: 321